Community Research and Development Information Service - CORDIS

Unleashing the curative potential of cancer immunotherapy

From 2018-07-01 to 2020-06-30, ongoing project

Project details

Total cost:

EUR 2 528 750

EU contribution:

EUR 1 770 125

Coordinated in:

Finland

Call for proposal:

H2020-SMEInst-2018-2020-2See other projects for this call

Funding scheme:

SME-2 - SME instrument phase 2

Objective

Coordinator

TILT BIOTHERAPEUTICS OY
Finland

EU contribution: EUR 1 770 125


HAARTMANINKATU 3 C
00290 HELSINKI
Finland
See on map
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top